Literature DB >> 1637789

Abnormalities of VLDL, IDL, and LDL characterize insulin-dependent diabetes mellitus.

P H Winocour1, P N Durrington, D Bhatnagar, M Ishola, S Arrol, M Mackness.   

Abstract

To identify abnormalities of serum lipoprotein composition and concentration that were specific to insulin-dependent diabetes mellitus (IDDM), the procedure of discontinuous gradient ultracentrifugation was employed to isolate lipoprotein fractions in 44 patients with IDDM, 24 nondiabetic subjects with similar lipid and lipoprotein concentrations, and 19 healthy normocholesterolemic (less than 5.2 mmol/l [less than 200 mg/dl]) subjects. The mass concentration of low density lipoprotein (LDL) was greater in IDDM than in both control groups. The free cholesterol to phospholipid ratio in large very low density lipoprotein (VLDL) was greatest in IDDM in comparison with both of the other groups. The contribution of triglyceride to total large VLDL mass was greater, whereas that of phospholipids was lower, in IDDM than in the dyslipidemic nondiabetic group. Protein concentration was reduced and phospholipid increased in small VLDL in IDDM in comparison with both control groups, and the contribution from protein to lipoprotein mass was least in IDDM. Similarly in intermediate density lipoprotein (IDL), the protein concentration and its contribution to overall mass was also lower in IDDM than in either control group, but by contrast, the phospholipid content was increased. The cholesteryl ester to protein ratio was highest in both small VLDL and IDL in IDDM in comparison with both control groups, whereas the free cholesterol to phospholipid ratio in IDL was least in IDDM. In LDL, total cholesterol and triglyceride concentrations were greatest and the contribution from protein to lipoprotein mass was least in IDDM in comparison with both control groups. The LDL free cholesterol to phospholipid ratio was greater in IDDM than in dyslipidemic control subjects.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1637789     DOI: 10.1161/01.atv.12.8.920

Source DB:  PubMed          Journal:  Arterioscler Thromb        ISSN: 1049-8834


  7 in total

1.  Hypercholesterolemic LDL receptor-deficient mice mount a neutrophilic response to tuberculosis despite the timely expression of protective immunity.

Authors:  Gregory W Martens; Therese Vallerskog; Hardy Kornfeld
Journal:  J Leukoc Biol       Date:  2012-01-06       Impact factor: 4.962

2.  Normal metabolism of apolipoprotein B100-containing lipoproteins despite qualitative abnormalities in type 1 diabetic men.

Authors:  L Duvillard; E Florentin; M L Lalanne-Mistrich; J M Petit; S Baillot-Rudoni; A Brun-Pacaud; J M Brun; P Gambert; B Vergès
Journal:  Diabetologia       Date:  2005-05-26       Impact factor: 10.122

3.  Very low density lipoprotein subfraction abnormalities in IDDM patients: any effect of blood glucose control?

Authors:  L Patti; L Di Marino; A Maffettone; G Romano; G Annuzzi; G Riccardi; A A Rivellese
Journal:  Diabetologia       Date:  1995-12       Impact factor: 10.122

4.  Glibenclamide or metformin combined with honey improves glycemic control in streptozotocin-induced diabetic rats.

Authors:  Omotayo Owomofoyon Erejuwa; Siti Amrah Sulaiman; Mohd Suhaimi Ab Wahab; Kuttulebbai Nainamohammed Salam Sirajudeen; Md Salzihan Md Salleh; Sunil Gurtu
Journal:  Int J Biol Sci       Date:  2011-03-14       Impact factor: 6.580

5.  Renoprotective effect of hydroalcoholic extract of Rheum ribes root in diabetic female rats.

Authors:  Shokri Hamzeh; Farah Farokhi; Reza Heydari; Ramin Manaffar
Journal:  Avicenna J Phytomed       Date:  2014-11

6.  Nigerian Honey Ameliorates Hyperglycemia and Dyslipidemia in Alloxan-Induced Diabetic Rats.

Authors:  Omotayo O Erejuwa; Ndubuisi N Nwobodo; Joseph L Akpan; Ugochi A Okorie; Chinonyelum T Ezeonu; Basil C Ezeokpo; Kenneth I Nwadike; Erhirhie Erhiano; Mohd S Abdul Wahab; Siti A Sulaiman
Journal:  Nutrients       Date:  2016-02-24       Impact factor: 5.717

7.  Implications of serum paraoxonase activity in obesity, diabetes mellitus, and dyslipidemia.

Authors:  Sunil K Kota; Lalit K Meher; Siva K Kota; Sruti Jammula; S V S Krishna; Kirtikumar D Modi
Journal:  Indian J Endocrinol Metab       Date:  2013-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.